TAKING STOCK - Taking Stock
- EAPM Director Dialogues - Arturo Chiti
Arturo Chiti is the President of the European Association of Nuclear Medicine and is based at the Istituto Clinico Humanitas in Italy.
As he says: “Our field is nuclear medicine, which is, of course, well-connected to imaging and is also connected with treatments. The common denominator of nuclear medicine is the use of radio-pharmaceuticals. These radio-pharmaceuticals are able to produce imaging of particular metabolic or pathologic processes and, by targeting a particular organ or structure we can also do therapy.”
- EAPM Director Dialogues - Anastassia Negrouk
Anastassia Negrouk is the Head of the International Policy Office at EORTC.
Speaking about how science (and how personalised medicine) has changed the game in cancer, she said: “We know more and more about how cancer develops, and cancer biology in general, and there is a need to better adapt the treatments to the individual profile of each patient, and to the cancer that they have in particular.
- EAPM Director Dialogues - Ken Mastris
Londoner Ken Mastris is chairman of Europa Uomo, the European advocacy movement for the fight against prostate cancer.
The organisation is based in Antwerp, Belgium, and is a European coalition of patients’ supporting groups for prostate diseases in general and prostate cancer in particular.
Talking about advances in personalised medicine, Ken says: “I believe there’s a lot of work being done on the early stages of prostate cancer, and the message is getting across. But still, men are suffering in silence – not talking to their GPs because they think it might be a weakness.
- EAPM Director Dialogues - Brigitte Grube
Brigitte Grube, of the Danish Oncology Nursing Society, is also Past President of EONS and chairs its advocacy group. In Vienna at the ECCO/ESMO congress, she was asked about the advances in personalised medicine in her field and the gaps and needs.
She focused straight away on education, saying: “We can see that the whole demography is changing, and we have more elderly people and that creates pressure for primary care. And many of the nurses in primary care in hospitals across Europe don’t have a specialist education. We can see that there is a need for specialist nurses in cancer care.
- EAPM Director Dialogues - Roberto Salgado
Roberto Salgado is a molecular pathologist who received his medical training at the University Hospital of Antwerp, Belgium, and the University Hospital in Leiden in The Netherlands.
His PhD thesis was obtained through working with the Translational Cancer Research Group of the AZ Sint-Augustinus Hospital, Antwerp, as well as at the Department of Pathology at the University Hospital of Antwerp. Salgado studied the interactions of haemostasis and angiogenesis in breast cancer.
- EAPM Director Dialogues - Hendrik van Poppel
Professor Hendrik van Poppel is chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit Leuven.
He is the Admin. Secretary General of the European Association of Urology (EAU) with responsibilities for education and was the Director of the European Society of Surgical Oncology, while also being chairman of the Educational Office of the EAU, director of the European School of Urology and holding several other urological and oncological posts.
- EAPM Director Dialogues - Ian Banks
Ian Banks has been president of the European Men’s Health Forum since its launch in 2001.
He is a retired accident and emergency doctor and general practitioner as well as a former president of the Men’s Health Forum (England and Wales), past vice president of the International Society of Men’s Health, and past deputy editor of the Men’s Health Journal. He was, for six years, the medical editor for Men’s Health magazine. As well as several others, Banks penned the BBC book The Trouble with Men.